Novel strategy for soft tissue augmentation based on transplantation of fragmented omentum and preadipocytes

Teiichi Masuda, Masutaka Furue, Takehisa Matsuda

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

Current therapeutic procedures for soft tissue augmentation still lack the ability to induce rapidly formation of adipose tissue and its long-term stability, which is determined by rapid revascularization. The omentum is highly vascularized with microvascular endothelial cells (ECs) and is composed mainly of adipocytes that produce an enormously high level of vascular endothelial growth factor (VEGF). The aim of this study was to determine the potential usefulness of fragmented omentum tissues, with or without cotransplantation with preadipocytes, in soft tissue augmentation. Fragmented omentum tissues (approximately 500 mg) with or without preadipocytes (approximately 2.3 × 106) isolated from epididymal adipose tissues were transplanted under the dorsal skin of Wistar rats by percutaneous injection and the tissues were left under the skin for up to 12 weeks. Regardless of cotransplantation with preadipocytes, the general morphological features of the transplanted tissue were as follows. The transplanted tissues, the weight loss of which was limited to 30-40%, contained viable adipocytes and some pseudocysts surrounded by fibrotic septa with minor inflammatory cell infiltration. High levels of triacylglycerol content, capillary density, and VEGF production were observed in transplanted tissues 12 weeks postoperation. Cotransplantation with preadipocytes enhanced adipose tissue formation significantly. These observations strongly indicate that transplantation of fragmented omentum tissues or cotransplantation with preadipocytes may be a promising therapeutic procedure for soft tissue augmentation.

Original languageEnglish
Pages (from-to)1672-1683
Number of pages12
JournalTissue Engineering
Volume10
Issue number11-12
DOIs
Publication statusPublished - Jan 1 2004

Fingerprint

Tissue
Skin
Endothelial cells
Infiltration
Rats

All Science Journal Classification (ASJC) codes

  • Biotechnology
  • Biophysics
  • Cell Biology

Cite this

Novel strategy for soft tissue augmentation based on transplantation of fragmented omentum and preadipocytes. / Masuda, Teiichi; Furue, Masutaka; Matsuda, Takehisa.

In: Tissue Engineering, Vol. 10, No. 11-12, 01.01.2004, p. 1672-1683.

Research output: Contribution to journalArticle

@article{33a01101d02a4a74bda7a74cc5110634,
title = "Novel strategy for soft tissue augmentation based on transplantation of fragmented omentum and preadipocytes",
abstract = "Current therapeutic procedures for soft tissue augmentation still lack the ability to induce rapidly formation of adipose tissue and its long-term stability, which is determined by rapid revascularization. The omentum is highly vascularized with microvascular endothelial cells (ECs) and is composed mainly of adipocytes that produce an enormously high level of vascular endothelial growth factor (VEGF). The aim of this study was to determine the potential usefulness of fragmented omentum tissues, with or without cotransplantation with preadipocytes, in soft tissue augmentation. Fragmented omentum tissues (approximately 500 mg) with or without preadipocytes (approximately 2.3 × 106) isolated from epididymal adipose tissues were transplanted under the dorsal skin of Wistar rats by percutaneous injection and the tissues were left under the skin for up to 12 weeks. Regardless of cotransplantation with preadipocytes, the general morphological features of the transplanted tissue were as follows. The transplanted tissues, the weight loss of which was limited to 30-40{\%}, contained viable adipocytes and some pseudocysts surrounded by fibrotic septa with minor inflammatory cell infiltration. High levels of triacylglycerol content, capillary density, and VEGF production were observed in transplanted tissues 12 weeks postoperation. Cotransplantation with preadipocytes enhanced adipose tissue formation significantly. These observations strongly indicate that transplantation of fragmented omentum tissues or cotransplantation with preadipocytes may be a promising therapeutic procedure for soft tissue augmentation.",
author = "Teiichi Masuda and Masutaka Furue and Takehisa Matsuda",
year = "2004",
month = "1",
day = "1",
doi = "10.1089/ten.2004.10.1672",
language = "English",
volume = "10",
pages = "1672--1683",
journal = "Tissue Engineering",
issn = "1076-3279",
publisher = "Mary Ann Liebert Inc.",
number = "11-12",

}

TY - JOUR

T1 - Novel strategy for soft tissue augmentation based on transplantation of fragmented omentum and preadipocytes

AU - Masuda, Teiichi

AU - Furue, Masutaka

AU - Matsuda, Takehisa

PY - 2004/1/1

Y1 - 2004/1/1

N2 - Current therapeutic procedures for soft tissue augmentation still lack the ability to induce rapidly formation of adipose tissue and its long-term stability, which is determined by rapid revascularization. The omentum is highly vascularized with microvascular endothelial cells (ECs) and is composed mainly of adipocytes that produce an enormously high level of vascular endothelial growth factor (VEGF). The aim of this study was to determine the potential usefulness of fragmented omentum tissues, with or without cotransplantation with preadipocytes, in soft tissue augmentation. Fragmented omentum tissues (approximately 500 mg) with or without preadipocytes (approximately 2.3 × 106) isolated from epididymal adipose tissues were transplanted under the dorsal skin of Wistar rats by percutaneous injection and the tissues were left under the skin for up to 12 weeks. Regardless of cotransplantation with preadipocytes, the general morphological features of the transplanted tissue were as follows. The transplanted tissues, the weight loss of which was limited to 30-40%, contained viable adipocytes and some pseudocysts surrounded by fibrotic septa with minor inflammatory cell infiltration. High levels of triacylglycerol content, capillary density, and VEGF production were observed in transplanted tissues 12 weeks postoperation. Cotransplantation with preadipocytes enhanced adipose tissue formation significantly. These observations strongly indicate that transplantation of fragmented omentum tissues or cotransplantation with preadipocytes may be a promising therapeutic procedure for soft tissue augmentation.

AB - Current therapeutic procedures for soft tissue augmentation still lack the ability to induce rapidly formation of adipose tissue and its long-term stability, which is determined by rapid revascularization. The omentum is highly vascularized with microvascular endothelial cells (ECs) and is composed mainly of adipocytes that produce an enormously high level of vascular endothelial growth factor (VEGF). The aim of this study was to determine the potential usefulness of fragmented omentum tissues, with or without cotransplantation with preadipocytes, in soft tissue augmentation. Fragmented omentum tissues (approximately 500 mg) with or without preadipocytes (approximately 2.3 × 106) isolated from epididymal adipose tissues were transplanted under the dorsal skin of Wistar rats by percutaneous injection and the tissues were left under the skin for up to 12 weeks. Regardless of cotransplantation with preadipocytes, the general morphological features of the transplanted tissue were as follows. The transplanted tissues, the weight loss of which was limited to 30-40%, contained viable adipocytes and some pseudocysts surrounded by fibrotic septa with minor inflammatory cell infiltration. High levels of triacylglycerol content, capillary density, and VEGF production were observed in transplanted tissues 12 weeks postoperation. Cotransplantation with preadipocytes enhanced adipose tissue formation significantly. These observations strongly indicate that transplantation of fragmented omentum tissues or cotransplantation with preadipocytes may be a promising therapeutic procedure for soft tissue augmentation.

UR - http://www.scopus.com/inward/record.url?scp=11144247061&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11144247061&partnerID=8YFLogxK

U2 - 10.1089/ten.2004.10.1672

DO - 10.1089/ten.2004.10.1672

M3 - Article

C2 - 15684676

AN - SCOPUS:11144247061

VL - 10

SP - 1672

EP - 1683

JO - Tissue Engineering

JF - Tissue Engineering

SN - 1076-3279

IS - 11-12

ER -